B7-H4

Citius Oncology Reports Promising LYMPHIR Cancer Data

CRANFORD, N.J., June 1, 2026 Citius Oncology has announced encouraging Phase 1 clinical findings evaluating LYMPHIR® (denileukin diftitox-cxdl) in...

By cGxPwire Editor
June 2, 2026

Pharma

Servier’s Emi-Le Shows Promise in Rare ACC Cancer Trial

BOSTON, June 1, 2026 Servier has announced encouraging new clinical findings for Emiltatug Ledadotin (Emi-Le), an investigational B7-H4-targeted antibody-drug...

By cGxPwire Editor
June 2, 2026

Bio-Pharma

GSK Reports Strong ADC Data in Ovarian Cancer Study

London, United Kingdom | April 13, 2026 GSK plc has announced positive clinical data from its Phase 1 BEHOLD-1...

By cGxPwire Editor
April 14, 2026

M&A

Day One Biopharma Acquires Mersana to Advance ADC Pipeline

BRISBANE, CA – November 13, 2025 — Day One Biopharmaceuticals announced a definitive agreement to acquire Mersana Therapeutics in...

By cGxPwire Editor
November 13, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Citius Oncology Reports Promising LYMPHIR Cancer Data

Servier’s Emi-Le Shows Promise in Rare ACC Cancer Trial

GSK Reports Strong ADC Data in Ovarian Cancer Study

Day One Biopharma Acquires Mersana to Advance ADC Pipeline